The market is reacting to a worse case scenario on this illness. In societies with good access to healthcare and treatment, the mortality rate isn't very different from influenza, which kills 14,000 people in the US every season and no one freaks about that.

The market is reacting to uncertainty because of the lack of data of this strain - and as the data continues to place it closer and closer to what we are used to dealing with, the market will recover and people will be back at work.

These Teslas and iPhones aren't being assembled by immunocompromised elderly without easy access to medicine, they're being assembled by young people in close proximity to major health infrastructure.